null
ChEBI ID: 48133
| Member | Definition | Role |
|---|---|---|
| 1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate | 1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate | |
| borreverine | Borreverine | |
| eseroline | A pyrroloindole that is 1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole substituted by methyl groups at positions 1, 3a and 8 and a hydroxy group at position 5. It is a metabolite of physostigmine and causes neuronal cell death by a mechanism involving loss of cell ATP. | eseroline |
| quadrigemine a | Quadrigemine A | |
| quilostigmine | quilostigmine | |
| roquefortine | (4E)-4-(1H-Imidazol-5-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-10,12,14-triene-3,6-dione | |
| roquefortine | Roquefortine C | |
| sb 206553 | SB 206553 |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 24 (11.16) | 18.7374 |
| 1990's | 36 (16.74) | 18.2507 |
| 2000's | 85 (39.53) | 29.6817 |
| 2010's | 56 (26.05) | 24.3611 |
| 2020's | 14 (6.51) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (0.44%) | 5.53% |
| Reviews | 5 (2.18%) | 6.00% |
| Case Studies | 7 (3.06%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 216 (94.32%) | 84.16% |